Blood Cancer UK
Trials
Collaborator, Phase 3, Recruiting, 1,226 people, Jun 16, 2026
Collaborator, Phase 2, Status unknown, 120 people, Aug 10, 2021
Collaborator, Phase 2, Active, not recruiting, 72 people, Apr 2, 2019
Collaborator, Phase 2, Completed, 36 people, Apr 26, 2016
Collaborator, Phase 2, Completed, 31 people, Apr 23, 2015
Funded papers
The Role of EVs in the Aging Hematopoietic System
23001, Oct 1, 2026
6701-25, Sep 22, 2026
Hematopoietic stem cell fitness mechanisms
Sep 7, 2026
The prevalence and clinical significance of clonal monocytosis
Jun 18, 2026
Jun 9, 2026
12002, May 28, 2026
Mar 29, 2026
Metabolite-induced DNA damage drives stochastic stem cell loss and clonal hematopoiesis
Mar 23, 2026
Harnessing genomics for early cancer detection, risk stratification and prevention
7035-34, 7035-24, Mar 2, 2026
13039, Aug 28, 2025
Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time
23001, Jul 17, 2025
15012, Jun 20, 2025
Clonal tracing with somatic epimutations reveals dynamics of blood ageing
13008, May 21, 2025
23001, May 14, 2025
Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1
13008, Apr 23, 2025
Clonal dynamics after allogeneic haematopoietic cell transplantation
15008, Oct 30, 2024
Lipoprotein(a) and cardiovascular disease
Sep 12, 2024
13008, Jun 24, 2024
13042, 19004, Mar 13, 2024
A life-time of hematopoietic cell function: ascent, stability, and decline
18010, Mar 5, 2024
Sources: api.crossref.org, openalex.org